Breast Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology

J. Gradishar, William; S. Moran, Meena; Abraham, Jame; Aft, Rebecca; M. Agnese, Doreen; H. Allison, Kimberly; Anderson, Bethany; J. Burstein, Harold; K. Chew, Helen; T. Dang, Chau; Elias, Anthony; H. Giordano, Sharon; P. Goetz, Matthew; J. Goldstein, Lori; A. Hurvitz, Sara; J. Isakoff, Steven; C. Jankowitz, Rachel; H. Javid, Sara; Krishnamurthy, Jairam; Leitch, Marilyn; A. Lyons, Janice; Mortimer, Joanne; A. Patel, Sameer; J. Pierce, Lori; H. Rosenberger, Laura; S. Rugo, Hope; M. Sitapati, Amy; L. Smith, Karen; Lou Smith, Mary; Soliman, Hatem; Stringer-Reasor, Erica; L. Telli, Melinda; H. Ward, John; B. Wisinski, Kari; Young, Jessica; L. Burns, Jennifer; Kumar, Rashmi

doi:10.6004/jnccn.2022.0030

Public

Breast Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology

Published in Journal of the National Comprehensive Cancer Network • Jun 1, 2022

Authors:

William J. Gradishar

Meena S. Moran

Jame Abraham

Abstract

The therapeutic options for patients with noninvasive or invasive breast cancer are complex and varied. These NCCN Clinical Practice Guidelines for Breast Cancer include recommendations for clinical management of patients with carcinoma in situ, invasive breast cancer, Paget disease, phyllodes tumor...

Subject

Medicine

Breast cancer

Cancer

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!